Shortcut menu
Go to content
Go to footer

Korean

DONG-A ST - We vow to endeavor to promote human health.

HOME>Business Areas>Overseas Business

Overseas Business

Backed by a history of successful product development and strong R&D capabilities, Dong-A ST is entering exciting new markets.
  • Overseas Sales

    Dong-A is following an R&D-driven approach to global expansion. Unique in the domestic industry, Dong-A is establishing a presence in the world markets based on its own pipeline, which has produced such high-profile ethical drugs as Stillen® (gastritis), Zydena® (erectile dysfunction), and Gonadopin® (infertility). The company is now developing its international brand value through an enhanced focus on global marketing.

  • COUNTRIES WITH EXPORT CONTRACTS

    Countries with export contacts

    • North Americastrong :United states
    • South America : Guatemala, Brazil, Argentina, Chile
    • Oceania :Guam, Saipan, New Zealand
    • Europe :UK, Germany, France, Netherlands, Spain,
      WHO, Turkey, Ukraine, Russia, Georgia, CIS
    • Asia :Malaysia, Mongolia, Myanmar, Bangladesh, Vietnam, Singapore, India, Japan,
      China, Cambodia, Thailand, Pakistan, Philippines, Indonesia, Kazakhstan, Laos, Sri Lanka, DPRK
    • The Middle East and Africa :Jordan, UAE, Iraq, Namibia, Morocco, Botswana, Syria, Algeria,
      Saudi Arabia, Nigeria, Republic of South Africa, Ghana, Iran
  • PRODUCTS

    Ⅰ. Rx PRODUCTS

    ① BIOLOGICAL PRODUCTS

    BIOLOGICAL PRODUCTS
    PRODUCT INDICATION STATUS
    EPORON® Inj.
    (Recombinant Erythropoietin
    1000, 2000, 4000IU)
    Anemia associated with chronic renal failure Launched
    EPORON® Prefilled Syringe
    (Recombinant Erythropoietin
    1000, 2000, 3000, 4000, 5000, 6000, 10000IU)
    Launched
    GROWTROPIN®II for Inj.
    (Recombinant Somatropin
    4IU, 12IU, 16IU)
    Growth failure due to an inadequate secretion of growth hormone Launched
    GROWTROPIN®AQ Inj.(Recombinant Somatropin
    4IU, 12IU, 16IU)
    Launched
    GROWTROPIN® Cartridge (Pen)
    (Recombinant Somatropin 30IU)
    Launched
    LEUCOSTIM® Inj.
    (Recombinant Filgrastim
    75㎍, 150㎍, 300㎍, 480㎍)
    Neutropenia in patients receiving myelosuppressive chemotherapy, etc.
    Launched
    GONADOPIN® Inj.
    (Recombinant Follitropin
    75IU, 150IU)
    Assisted reproduction Launched
    GONADOPIN®NF(PFS)
    (Recombinant Follitropin
    75IU, 150IU, 225IU, 300IU)
    Launched

    ② FINISHED PRODUCTS

    FINISHED PRODUCTS
    PRODUCT COMPOSITION APPLICATION
    ZYDENA® Tab.
    (PDE-5 Inhibitor)
    Udenafil 50mg, 100mg, 200mg Erectile dysfunction
    SUGANON® Tab.
    /SUGAMET® XR Tab.
    (DPP-4 inhibitor)
    Evogliptin 5mg
    Evogliptin/Metformin 2.5mg/500mg, 2.5mg/850mg, 5mg/1000mg
    Type 2 diabetes mellitus
    STILLEN® Tab.
    (Anti-Gastritis)
    Artemisiae argyi folium ext. 60mg Gastrointestinal diseases including acute and chronic gastritis
    MOTILITONE® Tab.
    (Functional Dyspepsia)
    Corydalis tuber & Pharbitis seed Ext. 30mg Functional dyspepsia
    CLOSERIN® Cap.
    (Anti-Tuberculosis)
    Cycloserine 250mg Active pulmonary,
    Extra-pulmonary tuberculosis
    PLAVITOR® Tab.
    (Anti-Coagulants)
    Clopidogrel 75mg Stroke, Heart attack, Peripheral artery disease (P.A.D.)

    Ⅱ. API

    ① ACTIVE PHARMACEUTICAL INGREDIENTS (API)

    GENERIC
    CLASSIFICATION GENERIC NAME SPECIFICATION PACKING STAGE
    Anti-Hyperlipidemia Atorvastatin calcium
    trihydrate (Form I & D2)
    JP, EP, USP 10kg, 20kg, 50kg Launched
    Anti-Tuberculosis D-Cycloserine
    Terizidone
    USP
    In House
    37kg
    28kg
    Launched
    Anti-Fungal Voriconazole USP, EP 3kg, 6kg Launched

    Ⅲ. OTC PRODUCTS

    ① Functional food

    GENERIC
    PRODUCT INGREDIENTS EFFICACY
    Bacchus Taurine, Vitamin B Complex, Caffeine, Ginseng Ext, Inositol, Nicotinamide, L-lysine, Royal Jelly, Pyridoxine, Riboflavin Energy Booster
    Bacchus
    Sugar Free
    Taurine, Vitamin B Complex, Caffeine, Ginseng Ext, Inositol, Nicotinamide, L-lysine, Royal Jelly, Pyridoxine, Riboflavin
    Energy Booster
    Bacchus-X Taurine, Vitamin B Complex, Caffeine, Ginseng Ext, Inositol, Nicotinamide, L-lysine, Royal Jelly, Pyridoxine, Riboflavin Energy Booster
    Morning Care® GMT-ALC-5L (unembroidered soy bean fermentation extract - nut baterium, from Japan), milk thistle extract powder, guarana extract powder, honey (from Korea) Relief of hangover symptoms
    Vitagran-C® Vitamin C, high fructose com syrup, white sugar, alcohol, concentrate extract of apple juice, citric acid anhydrous, taurine, guarana extract powder, nicotine acid amid, Vitamin C supplement

    ② Non-prescription medicine

    GENERIC
    PRODUCT INGREDIENTS EFFICACY
    Circulan®Cap. Crataegus oxyacantha: 50mg, Melissa lobe: 10mg, Gingko leaf: 5mg Symptoms due to blood circulation disorders
    Amcilon®Q Tab. Acetaminophen: 300mg, and ethenzamid: 300mg Relief of pains (headache, toothache, pain after tooth extraction, sore throat
    CNQ®Cap. Coenzyme Q10, Manganese Sulfate, Zinc Oxide, β-Carotene 30% Suspension, Ascorbic Acid, Selenium in dried yeast, Tocopherol Acetate Supply of Vitamin A,C, E and zinc
    Scapula® Tab. Caffeine Hydrate25mg, Chlorzoxazone150mg, Ethenzamide150mg Relief of skeletal muscle spasm and pain
    Noscarna®Gel Allantoin50mg/g, Dexpanthenol100mg/g, Heparin Sodium500IU/g Treating and reducing scars

  • PIPELINE PRODUCTS
    ENERGY DRINK/DRINKS
    CATEGORY PRODUCT APPLICATION STATUS
    Anti-Inflammatory
    Agent
    DA-6034 Gastritis
    Dry eye
    Phase III
    Phase II
    Herbal Medicine DA-9801 Diabetic Neuropathy Phase II
    PDE5 Inhibitor DA-8159 Portal hypertension
    Benign prostatic hyperplasia
    Pulmonary arterial hypertension
    Phase II
    Phase II
    Phase II
    5-HT4 agonist DA-6886 Irritable bowel Syndrome(constipation) Phase I
    Anti-Diabetic Agent DA-1229
    DA-3091
    Diabetes mellitus
    Diabetes mellitus
    Phase III
    Phase I
    SERT Inhibitor DA-8031 Premature ejaculation Phase II
    Recombinant Protein DA-3051
    (Interferon-beta)
    DA-3808
    (Antihemophilic Factor (rAHF))
    DMB-3111
    (Therapeutic Antibody)
    DA-3801
    (Recombinant Follitropin)
    DA-3803
    (Choriogonadotropin)
    DA-3031
    (PEG-Filgrastim)
    Multiple sclerosis

    Hemophilia A

    HER2 positive breast
    cancer
    Anovulation

    Infertility

    Neutropenia

    Phase I
    (Brazil)
    Preclinical

    Preclinical

    Phase III

    Phase III

    Phase III

PRIVACY POLICY

  1. Introduction

    This Privacy Policy describes the personally identifiable information that Dong-A ST ("the Company") collects through our Web site located at en.donga-st.com and how we use that information. If you have any questions or comments about this Privacy Policy or our practices regarding your personally identifiable information, please contact us via email or by phone.

  2. Collection of Personal Information

    You can browse our Web site without providing us with any personal information. However, the Company collects your personal information within the scope of its business activities for clearly defined purposes.

  3. Disclosure of Personal Information

    The Company will not disclose, rent, sell or otherwise transfer your personal information without your consent, except as otherwise set out in this Privacy Policy. The Company uses personal information within the limits necessary for the achievement of its objectives.

    The Company may share information provided by our visitors to en.donga-st.com with service providers we have retained to perform services on our behalf. These service providers are contractually restricted from using or disclosing the information except as necessary to perform services on our behalf or to comply with legal requirements. In addition, we may disclose information about you (i) if we are required to do so by law or legal process, (ii) to law enforcement authorities or other government officials, or (iii) when we believe disclosure is necessary or appropriate to prevent physical harm or financial loss or in connection with an investigation of suspected or actual illegal activity.

  4. Changes to this Privacy Policy

    The Company will review this policy in accordance with circumstances and revise it as needed. The revised Privacy Policy will be posted on this Web site. We will treat your personal information in accordance with the Privacy Policy in place at the time of collection of such information, or as you otherwise consent.

팝업 닫기

TERMS OF USE

This website is operated by Dong-A ST. All inquiries may be directed to:

Dong-A ST
64 Cheonhodaero, Dongdaemun-gu,
Seoul, Korea

Your use of this website is governed by these terms of use. Please take a few minutes to review these terms when using the Web site.

  1. Copyright Notice

    All of the content you see on this Web site, including, for example, all of images, illustrations, graphics, audio clips, video clips, and text, are subject to trademark, service mark, trade dress, copyright and/or other intellectual property rights or licenses held by Dong-A ST, one of its affiliates or by third parties who have licensed their materials to Dong-A ST. They may therefore not be used without the prior written consent of Dong-A ST for purposes other than to identify and present Dong-A ST’s products and service. The entire content of this Web site is protected under the copyright law of the relevant countries and international treaty. You may download, print and store selected portions of the content, provided you (1) only use these for your own personal, non-commercial use, (2) do not copy or post the content on any network computer or broadcast the content in any media, and (3) do not modify or alter the content in any way, or delete or change any copyright or trademark notice. Any use beyond the provisions outlined above is strictly prohibited

  2. Disclaimer

    While the information on this Web site is given in good faith based upon the latest available to Dong-A ST, no warranty or representation is given concerning such information, which must not be taken as establishing any contractual or other commitment binding upon Dong-A ST or any of its subsidiaries or associated companies.

  3. Changes

    Dong-A ST reserves the right, at its sole discretion, to change, modify, add or remove any portion of this Agreement in whole or in part, at any time. Changes in this Agreement will be effective when notice of such change is posted. Your continued use of the Site after any changes to this Agreement are posted will be considered acceptance of those changes. Dong-A ST may terminate, change, suspend or discontinue any aspect of this Web site, including the availability of any features of the Site, at any time. Dong-A ST may also impose limits on certain features and services or restrict your access to parts or the entire Site without notice or liability.

  4. Linked Sites

    As a convenience to you, we may provide, on this site, links to Web sites operated by other entities. We do not control any of those linked Web sites, we may not have reviewed them, and we make no representations or warranties and assume no responsibility for anything that may happen through your use of any linked Web site. You should read carefully the terms of use of any other Web site that you may use.

팝업 닫기

DMB-3115 Data Protection Notice

Last Edited on [2023-05-02]

This Privacy Notice describes the personal data that Dong-A ST Co., Ltd. (hereafter “Dong-A”, “us”, “we”, “our”") collects through our website located at http://en.donga-st.com/Main.da that are specific to our product coded DMB-3115 in relation to all clinical trials and regulatory approvals in Europe and how we use and keep safe that information.

Dong-A as the Controller of the personal data has committed to comply with the General Data Protection Regulation N°EU 2016/679 (hereinafter, the "GDPR") and all EU applicable laws and regulations regarding data protection collectively referred as "Data Protection Laws". In compliance with the GDPR, we appointed Data Protection Officer listed below who performs his or her the tasks as required by the GDPR.

With this Privacy Notice, Dong-A aims at ensuring that you understand what personal information is collected about you, how your personal information is used and how it is kept safe.

GENERAL WARNING AND USE OF SOCIAL MEDIA

Access to the Website implies the User’s full and unreserved acceptance of this Privacy Notice (hereinafter the “Notice”), as well as its general terms of use. The User acknowledges having read the information below.

The Notice is valid for all pages hosted on the Website. It is not valid for the pages hosted by third parties to which we may refer and whose privacy notices may differ. Dong-A cannot therefore be held responsible for any data processed on these websites or by third parties. This Notice also applies to any other website that Dong-A may operate.

  1. 1. Why, how and for how long do we collect your personal data?

    We will only process your personal data in connection with specific purposes. We will keep them for no longer than necessary to fulfill the purposes for which we collected it, including any legal requirements.

    Depending on each case, the processing will therefore be as follows:

    Purposes Types of personal data Legal basis Retention period
    To answer to your queries Name, email address,

    Please note that other Personal Data may be processed by Dong-A depending on your request and the information you provide us.
    This processing is based on our legitimate interest in answering the requests or queries raised by you through the existing different contact channels. We understand that the processing of these data is also beneficial to you to the extent that it enables us to assist you adequately and answer to the queries raised. We will process your data for the time necessary to meet your request.
    For statistical purposes Aggregate statistical data We consider that we have lawful interest to understand the way our page is consulted (e.g., how many times our page is consulted, from which country, etc.). We may export statistical reports, but we guarantee that this is only in an anonymous form.
  2. 2. Data sharing

    We do not sell or trade your personal data to third parties.

    However, Dong-A has contracted with the following Services Providers to manage the Website that may have access to your personal data: - DA Information for Hosting.

    Sharing your personal data as explained above may involve a transfer of personal data to a country outside the European Economic Area (EEA), we are therefore committed to complying with the transfer rules under applicable Data Protection Laws and therefore ensure to:

    • Transfer your data to countries where the data recipient is located that has been recognized as adequate by the European Commission; or

    • Where a country has not received an adequacy decision from the European Commission, to implement appropriate safeguards, such as the EU Standard Contractual Clauses ("SCCs").

    You can contact our DPO (see contact details below) if you want to have more details about the mechanism supporting data transfer.

  3. 3. How do we protect your information?

    We process your personal data in a confidential manner and provide a sufficient and adequate level of protection of your personal data.

    Your personal data is housed behind secured networks and are only accessible by a limited number of persons who have special access rights to such systems and are required to keep the information confidential.

  4. 4. Your rights

    According to the GDPR, you have the following rights:

    - Access. You have the right to obtain confirmation as to whether or not personal data concerning you are being processed, and, where that is the case, information related to the processing of data and a copy of the data being processed.

    - Rectification. You have the right to require rectification of inaccurate data about you.

    - Right to be forgotten. To obtain the deletion of your personal data in the situations set forth by applicable data protection law.

    - Restrict processing. You have the right to restrict processing of data under certain specified circumstances.

    - Data portability. You have the right to request for the receipt or the transfer to another organization, in a machine-readable form, of your personal data.

    - Object to processing. You have the right to object, on grounds relating to your particular situation, at any time to the processing of your data.

    - Right to withdraw consent. When you have given your explicit consent for the processing of your data (e.g., Subscription to the Newsletter), you can withdraw it at any time without justification.

    Please note that all these rights are not absolute and will be assessed on a case-by-case basis by our Data Protection Officer (DPO).

    If you would like to exercise your rights, please let us know by contacting our DPO at dong-a.dpo@mydata-trust.info.

    You have also the right to lodge a complaint if you consider that your personal data is not processed in accordance with the GDPR.

    If you are an EEA resident: You have the right to lodge a complaint with the Data Protection Authority in the Member State of the European Union of your habitual residence, place of work or place of the alleged infringement.

    Please find the contact information of all Authorities in section 6 "Contacts".

  5. 5. Changes to this Privacy Notice

    This Notice is effective as of the date stated at the top of this page. We may change this Notice from time to time. Please refer back to this Notice on a regular basis.

  6. 6. Contacts

    If you have any questions or comments about this Notice or our practices regarding your personal data, please contact us.

    Dong-A ST Co. Ltd., acting as Controller
    64, Cheonho-Daero, Dongdaemun-Gu
    Seoul 02587, Republic of Korea
    email: st_ciso@donga.co.kr
    telephone: +82 2 920 8254

Data Protection Officer

MyData-TRUST SA
Boulevard Initialis, 7 bt 3 – 7000 Mons (BELGIUM)
email: dong-a.dpo@mydata-trust.info
telephone: +32 2 896 55 53

For EU Data Protection Authorities

https://edpb.europa.eu/about-edpb/about-edpb/members_en

팝업 닫기